About: Christoph Huber

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Christoph Huber Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
rdfs:label	Christoph Huber (en) Christoph Huber (nl) Christoph Huber (de)
skos:prefLabel	Christoph Huber (en) Christoph Huber (nl) Christoph Huber (de)
name	Christoph Huber (en) Christoph Huber (nl) Christoph Huber (de)
given name	wds:Q95028765-B8EA7869-0BB3-4F0C-AB28-FE73DD0CA287
given name	Christoph
described by source	wds:Q95028765-712FB5C3-55CD-4235-9C15-673A1CE68178
instance of	wds:Q95028765-D3C6EFC8-C0C9-4873-BD04-066061C7558E
described by source	Biographisches Lexikon des Kaiserthums Oesterreich
instance of	Homo sapiens
occupation	wds:Q95028765-55585BCA-EC71-4030-86CD-4201E82AA99B
sex or gender	wds:Q95028765-BEC49011-61CE-4B45-9C18-2B8A0876A86D
family name	wds:Q95028765-E3CEFB0C-C571-4B3F-AAD9-5D92BAAA3B19
occupation	researcher
sex or gender	male
family name	Huber
is owl:sameAs of	Christoph Huber Christoph Huber
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q95028765
is author of	Exploiting the mutanome for tumor vaccination. Intranodal vaccination with naked antigen-encoding RNA elicits potent prophylactic and therapeutic antitumoral immunity. Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells. Increased Antigen Presentation Efficiency by Coupling Antigens to MHC Class I Trafficking Signals Cerebrovascular accidents complicating transcatheter aortic valve implantation: frequency, timing and impact on outcomes Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation Cooperation of Human Tumor-Reactive CD4+ and CD8+ T Cells after Redirection of Their Specificity by a High-Affinity p53A2.1-Specific TCR Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering. Redirection of T cells by delivering a transgenic mouse-derived MDM2 tumor antigen-specific TCR and its humanized derivative is governed by the CD8 coreceptor and affects natural human TCR expression Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development Evaluation of genetic melanoma vaccines in cdk4-mutant mice provides evidence for immunological tolerance against authochthonous melanomas in the skin. Atrial fibrillation and aortic stenosis: impact on clinical outcomes among patients undergoing transcatheter aortic valve implantation Successful adenovirus-mediated wild-type p53 gene transfer in patients with bladder cancer by intravesical vector instillation The response of autologous T cells to a human melanoma is dominated by mutated neoantigens Predictors of functional decline in elderly patients undergoing transcatheter aortic valve implantation (TAVI). Frequent nonrandom activation of germ-line genes in human cancer. The regulatory landscape for actively personalized cancer immunotherapies Percutaneous management of vascular complications in patients undergoing transcatheter aortic valve implantation. Sustained complete molecular remissions after treatment with imatinib-mesylate in patients with failure after allogeneic stem cell transplantation for chronic myelogenous leukemia: results of a prospective phase II open-label multicenter study Targeting AKT signaling sensitizes cancer to cellular immunotherapy Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer Cancer classification using the Immunoscore: a worldwide task force Therapeutic vaccines for cancer: an overview of clinical trials A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr). CD8+ cytotoxic T lymphocytes isolated from allogeneic healthy donors recognize HLA class Ia/Ib-associated renal carcinoma antigens with ubiquitous or restricted tissue expression Dissection and molecular analysis of alloreactive CD8+ T cell responses in allogeneic haematopoietic stem cell transplantation Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy Results of a multicenter phase II trial for older patients with c-Kit-positive acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS) using low-dose Ara-C and Imatinib. Molecular design of the Calphabeta interface favors specific pairing of introduced TCRalphabeta in human T cells Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation Defining the critical hurdles in cancer immunotherapy Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer. Mutant MHC class II epitopes drive therapeutic immune responses to cancer Simultaneous ex vivo quantification of antigen-specific CD4+ and CD8+ T cell responses using in vitro transcribed RNA Rapid identification and sorting of viable virus-reactive CD4(+) and CD8(+) T cells based on antigen-triggered CD137 expression The human X chromosome is enriched for germline genes expressed in premeiotic germ cells of both sexes. The self-expanding Symetis Acurate does not increase cerebral microembolic load when compared to the balloon-expandable Edwards Sapien prosthesis: a transcranial Doppler study in patients undergoing transapical aortic valve implantation Transapical transcatheter aortic valve implantation using the second-generation self-expanding Symetis ACURATE TA valve. A neoepitope generated by an FLT3 internal tandem duplication (FLT3-ITD) is recognized by leukemia-reactive autologous CD8+ T cells An immune escape screen reveals Cdc42 as regulator of cancer susceptibility to lymphocyte-mediated tumor suppression A methodological framework to enhance the clinical success of cancer immunotherapy Clinical outcomes of patients with severe aortic stenosis at increased surgical risk according to treatment modality Long-term outcome of elderly patients with severe aortic stenosis as a function of treatment modality Predictors of clinical outcomes in patients with severe aortic stenosis undergoing TAVI: a multistate analysis Quality of life in high-risk patients: comparison of transcatheter aortic valve implantation with surgical aortic valve replacement. Transcatheter aortic valve implantation or surgical aortic valve replacement as redo procedure after prior coronary artery bypass grafting Sustained remissions and low rate of BCR-ABL resistance mutations with imatinib treatment chronic myelogenous leukemia in patients treated in late chronic phase: a 5-year follow up Aortic root dimensions among patients with severe aortic stenosis undergoing transcatheter aortic valve replacement Efficacy and safety of imatinib in adult patients with c-kit-positive acute myeloid leukemia Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma Transcranial Doppler-detected cerebral embolic load during transcatheter aortic valve implantation. FLT3 ligand enhances the cancer therapeutic potency of naked RNA vaccines. Short-term clinical outcomes among patients undergoing transcatheter aortic valve implantation in Switzerland: the Swiss TAVI registry Expression of multiple epigenetically regulated cancer/germline genes in nonsmall cell lung cancer. Procedural Results and Clinical Outcomes of Transcatheter Aortic Valve Implantation in Switzerland: An Observational Cohort Study of Sapien 3 Versus Sapien XT Transcatheter Heart Valves A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes Sustained complete hematologic remission after administration of the tyrosine kinase inhibitor imatinib mesylate in a patient with refractory, secondary AML. Altered expression of nonclassical HLA class Ib antigens in human renal cell carcinoma and its association with impaired immune response Partial tyrosinase-specific self tolerance by HLA-A*0201-restricted cytotoxic T lymphocytes in mice and man Selective activation of tumor growth-promoting Ca2+ channel MS4A12 in colon cancer by caudal type homeobox transcription factor CDX2. MS4A12 is a colon-selective store-operated calcium channel promoting malignant cell processes Validation of the Valve Academic Research Consortium Bleeding Definition in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation. Targeting positive regulatory domain I-binding factor 1 and X box-binding protein 1 transcription factors by multiple myeloma-reactive CTL The kinase inhibitor LS104 induces apoptosis, enhances cytotoxic effects of chemotherapeutic drugs and is targeting the receptor tyrosine kinase FLT3 in acute myeloid leukemia An open-label, prospective phase I/II study evaluating the immunogenicity and safety of a ras peptide vaccine plus GM-CSF in patients with non-small cell lung cancer Selective activation of trophoblast-specific PLAC1 in breast cancer by CCAAT/enhancer-binding protein beta (C/EBPbeta) isoform 2. Coexpression of the T-cell receptor constant alpha domain triggers tumor reactivity of single-chain TCR-transduced human T cells Impaired transporter associated with antigen processing (TAP) function attributable to a single amino acid alteration in the peptide TAP subunit TAP1. Repositionable Versus Balloon-Expandable Devices for Transcatheter Aortic Valve Implantation in Patients With Aortic Stenosis Predicting Mortality After Transcatheter Aortic Valve Replacement: External Validation of the Transcatheter Valve Therapy Registry Model. Cloning and functional analyses of the mouse tapasin promoter Long-term follow-up after implantation of the Shelhigh® No-React® complete biological aortic valved conduit Is surgery in acute aortic dissection type A still contraindicated in the presence of preoperative neurological symptoms?

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software